Investigating anticoagulant use for preventing blood clots in patients with inflammatory bowel disease
Anticoagulant use, safety, and effectiveness for venous thromboembolism prevention in inflammatory bowel disease patients
This study is looking at how well blood-thinning medications can help prevent blood clots in people with inflammatory bowel disease, both when they're in the hospital and at home, while also making sure these treatments are safe for those who might be at higher risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10893637 on NIH RePORTER |
What this research studies
This research focuses on improving the prevention and treatment of venous thromboembolism (VTE) in patients with inflammatory bowel disease (IBD). It aims to evaluate the effectiveness and safety of anticoagulants in both inpatient and outpatient settings, addressing the barriers that prevent their use in this population. The study will gather data on anticoagulant use, assess the risks of bleeding complications, and explore the safety of these medications in high-risk groups, such as those experiencing disease flares. By analyzing existing health records and conducting targeted assessments, the research seeks to provide evidence that can guide clinical practice for IBD patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with inflammatory bowel disease who may be at risk for developing venous thromboembolism.
Not a fit: Patients with conditions unrelated to inflammatory bowel disease or those who do not have a risk of venous thromboembolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies for blood clots in IBD patients, potentially reducing morbidity and mortality associated with VTE.
How similar studies have performed: While there has been some research on anticoagulant use in general populations, this specific focus on IBD patients is relatively novel and aims to fill significant gaps in existing literature.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Dawwas, Ghadeer K. — Vanderbilt University Medical Center
- Study coordinator: Dawwas, Ghadeer K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.